130 related articles for article (PubMed ID: 14757776)
1. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats.
Llinás MT; Alexander BT; Capparelli MF; Carroll MA; Granger JP
Hypertension; 2004 Mar; 43(3):623-8. PubMed ID: 14757776
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
Su P; Kaushal KM; Kroetz DL
Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677
[TBL] [Abstract][Full Text] [Related]
3. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6.
Gadonski G; LaMarca BB; Sullivan E; Bennett W; Chandler D; Granger JP
Hypertension; 2006 Oct; 48(4):711-6. PubMed ID: 16940225
[TBL] [Abstract][Full Text] [Related]
4. Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats.
Huang H; Zhou Y; Raju VT; Du J; Chang HH; Wang CY; Brands MW; Falck JR; Wang MH
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1116-22. PubMed ID: 15998843
[TBL] [Abstract][Full Text] [Related]
5. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats.
Llinás MT; Alexander BT; Seedek M; Abram SR; Crell A; Granger JP
Am J Hypertens; 2002 Sep; 15(9):793-7. PubMed ID: 12219874
[TBL] [Abstract][Full Text] [Related]
6. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats.
Novotny SR; Wallace K; Heath J; Moseley J; Dhillon P; Weimer A; Wallukat G; Herse F; Wenzel K; Martin JN; Dechend R; Lamarca B
Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1197-201. PubMed ID: 22461177
[TBL] [Abstract][Full Text] [Related]
7. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization.
Walsh SK; English FA; Johns EJ; Kenny LC
Hypertension; 2009 Aug; 54(2):345-51. PubMed ID: 19564546
[TBL] [Abstract][Full Text] [Related]
8. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure.
Alexander BT; Llinas MT; Kruckeberg WC; Granger JP
Hypertension; 2004 Apr; 43(4):832-6. PubMed ID: 14769812
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.
LaMarca B; Wallukat G; Llinas M; Herse F; Dechend R; Granger JP
Hypertension; 2008 Dec; 52(6):1168-72. PubMed ID: 18852381
[TBL] [Abstract][Full Text] [Related]
10. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
11. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.
Sholook MM; Gilbert JS; Sedeek MH; Huang M; Hester RL; Granger JP
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2080-4. PubMed ID: 17644567
[TBL] [Abstract][Full Text] [Related]
12. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats.
Gilbert J; Dukes M; LaMarca B; Cockrell K; Babcock S; Granger J
Am J Hypertens; 2007 Jun; 20(6):686-91. PubMed ID: 17531929
[TBL] [Abstract][Full Text] [Related]
13. Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia.
Vaka VR; McMaster KM; Cunningham MW; Ibrahim T; Hazlewood R; Usry N; Cornelius DC; Amaral LM; LaMarca B
Hypertension; 2018 Sep; 72(3):703-711. PubMed ID: 30012871
[TBL] [Abstract][Full Text] [Related]
14. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.
LaMarca BB; Bennett WA; Alexander BT; Cockrell K; Granger JP
Hypertension; 2005 Oct; 46(4):1022-5. PubMed ID: 16144982
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats.
Alexander BT; Cockrell K; Cline FD; Llinas MT; Sedeek M; Granger JP
Hypertension; 2001 Sep; 38(3 Pt 2):742-5. PubMed ID: 11566968
[TBL] [Abstract][Full Text] [Related]
17. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.
Alexander BT; Rinewalt AN; Cockrell KL; Massey MB; Bennett WA; Granger JP
Hypertension; 2001 Feb; 37(2 Pt 2):485-9. PubMed ID: 11230323
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.
LaMarca B; Speed J; Fournier L; Babcock SA; Berry H; Cockrell K; Granger JP
Hypertension; 2008 Dec; 52(6):1161-7. PubMed ID: 18981324
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.
Gilbert JS; Verzwyvelt J; Colson D; Arany M; Karumanchi SA; Granger JP
Hypertension; 2010 Feb; 55(2):380-5. PubMed ID: 20026764
[TBL] [Abstract][Full Text] [Related]
20. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.
Wallace K; Novotny S; Heath J; Moseley J; Martin JN; Owens MY; LaMarca B
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(2):R144-9. PubMed ID: 22647295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
